Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ASGR1 | P07306 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9604149 | 1.00 | PRKCA (0.35) | PRKCAEPHX2DGKAALDH1A1ASGR1 | |
| SCHEMBL9604155 | 1.00 | PRKCA (0.35) | PRKCAEPHX2DGKAALDH1A1ASGR1 | |
| SCHEMBL9604190 | 1.00 | PRKCA (0.35) | PRKCAEPHX2DGKAALDH1A1ASGR1 | |
| SCHEMBL9604152 | 1.00 | PRKCA (0.35) | PRKCAEPHX2DGKAALDH1A1ASGR1 | |
| SCHEMBL9604129 | 0.88 | CTDSP1 (0.40) | ALDH1A1 | |
| SCHEMBL9604148 | 0.88 | CTDSP1 (0.40) | ALDH1A1 | |
| SCHEMBL9604186 | 0.88 | CTDSP1 (0.40) | ALDH1A1 | |
| SCHEMBL9604119 | 0.88 | CTDSP1 (0.40) | ALDH1A1 | |
| SCHEMBL9604121 | 0.88 | CTDSP1 (0.40) | ALDH1A1 | |
| SCHEMBL9604153 | 0.88 | CTDSP1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157560-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120136070-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136070-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | KHK, HKDC1, HK2 | PRKCA 1744/4885EPHX2 304/4885DGKA 297/4885 |
| US-20120157560-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | KHK, HKDC1, HK2 | PRKCA 1744/4885EPHX2 304/4885DGKA 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.